Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-13-006124)

Filing Details

Accession Number:: 0001179110-13-006124
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-02 08:17:20
Reporting Period:: 2013-04-01

Filing Date:: 2013-04-02
Accepted Time:: 2013-04-02 08:17:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
855654	Immunogen Inc	IMGN	Pharmaceutical Preparations (2834)	042726691

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1198338	John Lambert	C/O Immunogen, Inc. 830 Winter Street Waltham MA 02451	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-04-01	11,250	$3.91	118,107	No	4	M	Direct
Common Stock	Disposition	2013-04-01	11,250	$15.81	106,857	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2013-04-01	11,250	$3.91	11,250	$3.91

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
22,500	2004-06-03	2013-06-03	No	4	M	Direct

Footnotes

Weighted average price of shares sold.
The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on February 1, 2013.
Exercisable as to 15,000 shares commencing on June 3, 2004, 15,000 shares commencing on June 3, 2005, and 15,000 shares commencing on June 3, 2006.